These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16278670)

  • 1. Stabilization of prolactin receptor in breast cancer cells.
    Li Y; Clevenger CV; Minkovsky N; Kumar KG; Raghunath PN; Tomaszewski JE; Spiegelman VS; Fuchs SY
    Oncogene; 2006 Mar; 25(13):1896-902. PubMed ID: 16278670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired turnover of prolactin receptor contributes to transformation of human breast cells.
    Plotnikov A; Varghese B; Tran TH; Liu C; Rui H; Fuchs SY
    Cancer Res; 2009 Apr; 69(7):3165-72. PubMed ID: 19276348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogene-mediated inhibition of glycogen synthase kinase 3 beta impairs degradation of prolactin receptor.
    Plotnikov A; Li Y; Tran TH; Tang W; Palazzo JP; Rui H; Fuchs SY
    Cancer Res; 2008 Mar; 68(5):1354-61. PubMed ID: 18316598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative regulation of prolactin receptor stability and signaling mediated by SCF(beta-TrCP) E3 ubiquitin ligase.
    Li Y; Kumar KG; Tang W; Spiegelman VS; Fuchs SY
    Mol Cell Biol; 2004 May; 24(9):4038-48. PubMed ID: 15082796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prolactin receptor transactivation domain is associated with steroid hormone receptor expression and malignant progression of breast cancer.
    Fiorillo AA; Medler TR; Feeney YB; Wetz SM; Tommerdahl KL; Clevenger CV
    Am J Pathol; 2013 Jan; 182(1):217-33. PubMed ID: 23159947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin induces up-regulation of its cognate receptor in breast cancer cells via transcriptional activation of its generic promoter by cross-talk between ERα and STAT5.
    Kavarthapu R; Tsai Morris CH; Dufau ML
    Oncotarget; 2014 Oct; 5(19):9079-91. PubMed ID: 25193864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin Receptor Expression is an Independent Favorable Prognostic Marker in Human Breast Cancer.
    Hachim IY; Hachim MY; Lopez VM; Lebrun JJ; Ali S
    Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):238-45. PubMed ID: 26317306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-evaluation of the prolactin receptor expression in human breast cancer.
    Galsgaard ED; Rasmussen BB; Folkesson CG; Rasmussen LM; Berchtold MW; Christensen L; Panina S
    J Endocrinol; 2009 Apr; 201(1):115-28. PubMed ID: 19153125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand-independent dimerization of the human prolactin receptor isoforms: functional implications.
    Gadd SL; Clevenger CV
    Mol Endocrinol; 2006 Nov; 20(11):2734-46. PubMed ID: 16840534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin stimulates ubiquitination, initial internalization, and degradation of its receptor via catalytic activation of Janus kinase 2.
    Swaminathan G; Varghese B; Thangavel C; Carbone CJ; Plotnikov A; Kumar KG; Jablonski EM; Clevenger CV; Goffin V; Deng L; Frank SJ; Fuchs SY
    J Endocrinol; 2008 Feb; 196(2):R1-7. PubMed ID: 18252943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CAML promotes prolactin-dependent proliferation of breast cancer cells by facilitating prolactin receptor signaling pathways.
    Lim JH; Kim TY; Kim WH; Park JW
    Breast Cancer Res Treat; 2011 Nov; 130(1):19-27. PubMed ID: 21128111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of prolactin receptor levels and activity in breast cancer.
    Swaminathan G; Varghese B; Fuchs SY
    J Mammary Gland Biol Neoplasia; 2008 Mar; 13(1):81-91. PubMed ID: 18204982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of prolactin and its receptor in human breast carcinoma.
    Reynolds C; Montone KT; Powell CM; Tomaszewski JE; Clevenger CV
    Endocrinology; 1997 Dec; 138(12):5555-60. PubMed ID: 9389544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prolactin receptor mediates HOXA1-stimulated oncogenicity in mammary carcinoma cells.
    Hou L; Xu B; Mohankumar KM; Goffin V; Perry JK; Lobie PE; Liu DX
    Int J Oncol; 2012 Dec; 41(6):2285-95. PubMed ID: 23064471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a novel and functional human prolactin receptor isoform (deltaS1PRLr) containing only one extracellular fibronectin-like domain.
    Kline JB; Rycyzyn MA; Clevenger CV
    Mol Endocrinol; 2002 Oct; 16(10):2310-22. PubMed ID: 12351696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New mechanisms for PRLr action in breast cancer.
    Clevenger CV; Gadd SL; Zheng J
    Trends Endocrinol Metab; 2009 Jul; 20(5):223-9. PubMed ID: 19535262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel and functional interaction between cyclophilin A and prolactin receptor.
    Syed F; Rycyzyn MA; Westgate L; Clevenger CV
    Endocrine; 2003; 20(1-2):83-90. PubMed ID: 12668872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Prolactin in Bone Metastasis and Breast Cancer Cell-Mediated Osteoclast Differentiation.
    Sutherland A; Forsyth A; Cong Y; Grant L; Juan TH; Lee JK; Klimowicz A; Petrillo SK; Hu J; Chan A; Boutillon F; Goffin V; Egan C; Tang PA; Cai L; Morris D; Magliocco A; Shemanko CS
    J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26586670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additive effects of a prolactin receptor antagonist, G129R, and herceptin on inhibition of HER2-overexpressing breast cancer cells.
    Scotti ML; Langenheim JF; Tomblyn S; Springs AE; Chen WY
    Breast Cancer Res Treat; 2008 Sep; 111(2):241-50. PubMed ID: 17955362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional and spatiotemporal regulation of prolactin receptor mRNA and cooperativity with progesterone receptor function during ductal branch growth in the mammary gland.
    Hovey RC; Trott JF; Ginsburg E; Goldhar A; Sasaki MM; Fountain SJ; Sundararajan K; Vonderhaar BK
    Dev Dyn; 2001 Oct; 222(2):192-205. PubMed ID: 11668597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.